We aim to demonstrate diagnostic accuracy of serial MPV measuring and to assess its correlation with cardiac troponin I (cTnI) levels . Design: Cross-sectional study. Methods: Consecutive patients presenting to emergency department with new onset chest pain started in the last four hours without electrocardiographic ST segment and T wave changes, pathological q waves were included in study. Complete blood count and cTnI levels were studied on admission and six hours after presentation. Patients with cTnI levels higher than 0.06 ng/ml were diagnosed as non-ST elevation myocardial infarction (NSTEMI) and other patients were matched as the control group. Results: NSTEMI group had significantly higher levels of MPV on admission and at the sixth hour. The increase in MPV was corraleted with elevation of cTnI levels. At six hours follow up, the increase in MPV levels predicted myocardial ischaemia (corrected r 2 =0.36; p=0.001) in linear regression analysis. The corresponding area under the receiver operating characteristic curve (ROC) for admission MPV, sixth hour MPV and increase in MPV levels in predicting myocardial ischaemia in patients with increased cTnI were 0.652, 0.727 and 0.896 respectively. If MPV threshold was selected as ≥0.10 fL during follow up, myocardial ischaemia was predicted with a sensitivity of 75% and specificity of 88%. Conclusions: Elevation of MPV levels in patients with acute chest pain may be an indicator of myocardial ischaemia. Serial MPV measurement can be used to complement serial cTnI measurements to diagnose NSTEMI.
Introduction
Acute coronary syndrome (ACS) is characterised by rupture of the unstable plaque and subsequent platelet rich thrombus formation leads to myocardial ischaemia with various clinical manifestations from unstable angina to ST segment elevation myocardial infarction (STEMI). Platelets play a crucial role in the pathogenesis of ACS. Mean platelet volume (MPV) is an indicator of active platelets and associated with their reactivity. 1 Increased levels of MPV are associated with larger and more active platelets. When compared with healthy individuals MPV is increased in patients with ACS and it is an independent risk factor for myocardial infarction. 2, 3 It is also an independent predictor of mortality in STEMI patient's treated with primary percutaneous coronary intervention. 4 It has been shown that MPV values vary between different ethnicities; furthermore, medications and illness also influence this value. 5 MPV measurement as a part of complete blood count is an easy, early and rapidly available marker in emergency departments and we wanted to assess if it has an additive diagnostic value in addition to serial cardiac troponin measurement in diagnosis of NSTEMI. Although, MPV levels are increased in ACS acute changes during first hours of myocardial ischaemia have not been investigated before.
In this study we aimed to show diagnostic accuracy of serial MPV measurement and its correlation with cTnI in the first 4 hours of NSTEMI, and also intended to assess if MPV has additional diagnostic value in addition to cTnI measurement.
Methods
A total of 208 (110 male, 98 female) patients older than eighteen years between June 2010 and March 2011 admitting to an emergency department of a tertiary cardiovascular disease branch teaching hospital, with new onset chest pain in first four hours without electrocardiographic ST segment and T wave changes, pathological q waves were prospectively enrolled in the study. Patients with liver and renal impairment, congestive heart failure, taking oral anticoagulant drugs, myeloproliferative disorders, anaemia, recent trauma, pregnancy, history of a previous myocardial infarction and coronary artery disease, patients with non-ACS elevation of troponin, initial electrocardiogram consistent with STEMI, were excluded from study. The study protocol was approved by ethics committee of the hospital and written informed consent was obtained from all patients.
Laboratory methods
Venous blood samples for complete blood count and cTnI levels were drawn immediately on admission and at the sixth hour. Patients with cTnI levels higher than 0.06 ng/ml on follow-up were diagnosed as NSTEMI and other patients were matched as the control group. Figure  2 ). If MPV threshold is selected ≥0.10 fL during follow up, myocardial ischaemia is predicted with a sensitivity of 75% and specificity of 88% (Figure 2 ). In multivariate logistic regression analysis using model adjusted for gender, age, hypertension, diabetes mellitus and smoking status elevation of MPV levels more than 0.10 fL was an independent predictor of myocardial infarction with an OR of 40.3 (CI 15.9-102.1, p<0.001).
Discussion
Despite remarkable progress in diagnosing patients with ACS, the identification of myocardial ischaemia is still challenging and physicians continue to overestimate the risk and admit low-risk patients. 6, 7 On the other hand 2-8% of patients presenting with chest pain whose final diagnosis is ACS are still sent home. 8 Cardiac markers (cardiac troponin I and T, creatinine kinase MB form), which are currently available, are not sufficiently sensitive at an early stage especially within 4 hours of the symptom onset due to the release of proteins from injured myocardium. 9 Hence a multimarker approach diagnosing ACS combining a p a n e l o f b i o m a r k e r s r e f l e c t i n g d i f f e r e n t pathophysiology might be clinically helpful. 10 An early and rapidly available independent marker for accurate diagnosis of ACS is required. This may lead to lower hospitalisation rates and avoid inappropriate discharges. 11 Platelets play a crucial role in the pathogenesis of acute coronary syndromes. Mean platelet volume (MPV) is an indicator of active platelets and associated with their reactivity. 1 Larger and hyperactive platelets play a pivotal role in accelerating the formation and propagation of intracoronary thrombus, leading to the occurrence of acute thrombotic events. 12 Unlike other studies in the literature this study was consisted of 4hour acute chest pain patients without ischaemic electrocardiographic changes and negative cardiac biomarkers. Also patients with a history of coronary artery disease who are high risk patients were excluded.
Higher MPV values are consistent with other studies in the literature in patients with ACS. 7, 13 Yilmaz et al observed a stepwise decrease in MPV between MI, UA and stable coronary artery disease among patients in Turkey. 13 Lippi et al reported that Italian patients with ACS had significantly higher MPV values than patients without ACS. 6 Chu et al found significantly higher MPV values in all Chinese ACS patients compared with non-ACS patients who presented to emergency department within four hours onset of chest pain. 10 Platelet activation and aggregation is a dynamic process during which platelets change their sizes and densities.
Most of the platelets in the circulation are consumed and new platelets are produced. The half-life of platelets in circulation is 10 days thus it is suggested that MPV is increased before ACS. Chu et al suggested this may be due to consumption of smaller platelets and production of large platelets. 11 In an Iranian study Mirzaie et al reported the patients in troponin positive group had higher MPV values than non-ACS patients with normal cardiac troponin T levels. 14 MPV measurement is also a good predictor for risk assessment and prognosis as it was shown in other studies.
Huczek et al found that MPV was an independent marker for angiographic reperfusion and mortality at 6 months. 15 Martin et al also concluded that MPV levels six months after ACS are a good predictor of adverse clinical events. 16 MPV reflects an atherosclerothrombic tendency in the human body. 11 Although most of the studies had reported that a raised admission MPV value could be a good predictor of ACS, it was shown that MPV values vary between different ethnicities. This study focused especially on serial measurement and its predictive power in diagnosing ACS. Our study showed that serial MPV measurement and rise in MPV levels at follow-up might add diagnostic value to patients with acute chest pain. Serial MPV measurement correlates well with cTnI measurement. In addition we supposed that MPV measurement could be an ideal part of a multimarker approach in diagnosing ACS with acute chest pain in emergency department.
In our study patients presented to our emergency department who were diagnosed as NSTEMI had a ratio of 47% which was inconsistent with most of the emergency departments. This could be explained as our centre is a tertiary training and teaching hospital specifically dealing with cardiovascular diseases. Nearly all the subject patients with acute chest pain were transferred to our centre with a pre-diagnosis of ACS.
Limitations of study
It is known that when EDTA is used as an anticoagulant MPV levels rise in a time-dependent manner and the amount of EDTA also affects platelet size. 17 To decrease EDTA effect on platelet size all blood samples were processed within 20 minutes following phlebotomy. In addition MPV levels might vary in different ethnicities, medications, obesity smoking aging and diabetes. [18] [19] [20] [21] 
Conclusions
We conclude that serial MPV measurement for acute chest pain in emergency departments can be a readily available laboratory test complementing the predictive value of serial cTnI in diagnosing NSTEMI. It should be considered as a useful rule-out test along with other conventional cardiac biomarkers for the risk stratification and diagnosis of patients with chest pain. In future, studies on serial MPV measurement to predict ACS, risk stratification and prognosis estimation are worthy of consideration.
